levonorgestrel has been researched along with Menopause in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (32.76) | 18.7374 |
| 1990's | 10 (17.24) | 18.2507 |
| 2000's | 18 (31.03) | 29.6817 |
| 2010's | 8 (13.79) | 24.3611 |
| 2020's | 3 (5.17) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, JH | 1 |
| Bahamondes, L; Juliato, C; Laporte, M; Metelus, S; Peloggia, A; Versailles, JBE | 1 |
| Rousset-Jablonski, C | 1 |
| Davey, DA | 1 |
| Wildemeersch, D | 1 |
| Dietrich, H; Mittmann, K; Rouskova, D; Schumacher, U; Zimmermann, T | 1 |
| Bentolila, J; Boisserie-Lacroix, M; Bouzgarrou, M; Cavagni, P; Laumonier, H; Lebiez-Michel, N; Trillaud, H | 1 |
| Zahradnik, HP | 1 |
| Arina, R; Bermejo, A; del Carme Cuesta, M; Lete, I; Marín, JM; Martínez, M | 1 |
| Buyukbayrak, EE; Kars, B; Karsidag, AY; Ozyapi, AG; Pirimoglu, ZM; Solak, Y; Turan, MC; Unal, O | 1 |
| Atkins, KA; Hanley, KZ; Mentrikoski, MJ; Shah, AA | 1 |
| Guillebaud, J | 1 |
| Baldaszti, E; Löschke, K; Wimmer-Puchinger, B | 1 |
| Gel'tser, BI; Khludeeva, TA; Kotel'nikov, VN | 1 |
| Grenman, S; Halmesmäki, K; Hurskainen, R; Kivelä, A; Kujansuu, E; Paavonen, J; Teperi, J; Tiitinen, A; Yliskoski, M | 1 |
| Shulman, LP | 3 |
| de Wever, N; Janssens, D; Pylyser, K; Schacht, E; Wildemeersch, D | 1 |
| Sturdee, D | 1 |
| Ahr, A; Gaetje, R; Kaufmann, M; Scharl, A | 1 |
| Boubli, B; Brun, JL; Dallay, D; Descat, E | 1 |
| Koratamaddi, LP; Prasad, M | 1 |
| Blumenfeld, Z; Boulman, N; Leiba, R; Levy, Y; Linn, R; Shachar, S; Siegler, E | 1 |
| Inki, P | 1 |
| Varma, TR | 2 |
| Fåhraeus, L; Larsson-Cohn, U; Wallentin, L | 1 |
| Farish, E; Fletcher, CD; Hart, DM; Lindsay, R; Sharpe, GL | 1 |
| Kuusi, T; Nikkilä, EA; Sipinen, S; Tikkanen, MJ | 1 |
| Osborn, RA; Wren, BG | 1 |
| Elamsson, K; Englund, DE; Johansson, ED; Odlind, V; Victor, A | 1 |
| Burrows, GD; Dennerstein, L | 1 |
| Zaĭdieva, IaZ | 1 |
| Garnett, TJ; Holland, EF; Leather, AT; Studd, JW | 1 |
| Adami, HO; Bergström, R; Falkeborn, M; Lithell, H; Persson, I; Terént, A | 1 |
| Hippeläinen, M; Hulkko, S; Karppinen, K; Kupari, M; Ventilä, M; Voutilainen, S | 1 |
| Kauppila, A; Malinen, H; Penttinen, J; Sundström, H; Suvanto-Luukkonen, E | 1 |
| Schacht, E; Wildemeersch, D | 1 |
| Dastidar, P; Jaakkola, O; Jokela, H; Koivu, TA; Koivula, T; Lehtimäki, T; Nikkari, ST; Punnonen, R | 1 |
| Salbach, B; von Holst, T | 1 |
| Cypryk, K; Kowalska, E; Nadel, I; Pertyński, T; Sobczuk, A; Stetkiewicz, T | 1 |
| Christiansen, C; Hassager, C; Marslew, U; Svendsen, OL | 1 |
| Everett, M; Hay, AW; Purdie, DW | 1 |
| Andersson, K; Mattsson, LA; Rybo, G; Stadberg, E | 1 |
| Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM | 1 |
| Beastall, G; Farish, E; Fletcher, CD; Gray, CE; Hart, DM; Lindsay, R | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM; Le Donne, M | 1 |
| Aedo, AR; Diczfalusy, E; Landgren, BM; Sundén, M | 1 |
| Fotherby, K | 1 |
| Hirvonen, E; Kärkkäinen, J; Lipasti, A; Mälkönen, M; Manninen, V; Nuntila, J; Timonen, H | 1 |
| Stenman, UH; Vartiainen, E; Widholm, O; Ylöstalo, P | 1 |
| Fredricsson, B; Hirt, M; Lagrelius, A; Weintraub, L | 1 |
| Cajander, S; Holst, J; von Schoultz, B | 1 |
| Dooley, M; Fogelman, I; Montgomery, J; Murby, B; Savvas, M; Studd, JW | 1 |
| Garrett, D; Wren, B | 1 |
7 review(s) available for levonorgestrel and Menopause
| Article | Year |
|---|---|
Menopausal hormone therapy: a better and safer future.
Topics: Administration, Cutaneous; Administration, Oral; Endometrial Hyperplasia; Estrogens; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Progesterone; Progestins; Venous Thromboembolism | 2018 |
[Hormones and mammographic breast density].
Topics: Adult; Aged; Biopsy; Breast; Breast Neoplasms; Contraceptive Agents, Female; Diagnosis, Differential; Estrogen Replacement Therapy; Female; Gonadal Steroid Hormones; Hormones; Humans; Intrauterine Devices; Levonorgestrel; Mammography; Menopause; Menstrual Cycle; Middle Aged; Norpregnenes; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Sensitivity and Specificity; Tamoxifen | 2008 |
The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
Topics: Administration, Cutaneous; Administration, Oral; Adult; Breast Neoplasms; Cardiovascular Diseases; Contraceptive Agents, Female; Estradiol; Estrogen Replacement Therapy; Estrogens; Evidence-Based Medicine; Female; Hot Flashes; Humans; Levonorgestrel; Menopause; Middle Aged; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Risk Factors; United States; Women's Health | 2004 |
Levonorgestrel intrauterine system for endometrial protection.
Topics: Adult; Endometrial Hyperplasia; Female; Hormone Replacement Therapy; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged; Treatment Outcome; United Kingdom | 2006 |
A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone.
Topics: Androstenes; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menopause; Progesterone; Women's Health | 2006 |
[Endometrial hyperplasia: A review].
Topics: Biopsy; Endometrial Hyperplasia; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Hysteroscopy; Levonorgestrel; Menopause; Progestins; Uterine Hemorrhage; Uterus | 2006 |
Long-term use of the levonorgestrel-releasing intrauterine system.
Topics: Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menopause; Menorrhagia; Progestins; Randomized Controlled Trials as Topic; Sterilization, Reproductive | 2007 |
15 trial(s) available for levonorgestrel and Menopause
| Article | Year |
|---|---|
[Arterial hypertension in menopausal women: Clinical, functional, and pharmaco-economical aspects].
Topics: Circadian Rhythm; Diuretics; Drug Combinations; Drug Therapy, Combination; Estradiol; Female; Heart; Humans; Hypertension; Indapamide; Levonorgestrel; Menopause; Treatment Outcome | 2003 |
A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia-effect on FSH levels and menopausal symptoms.
Topics: Adult; Estradiol; Female; Follicle Stimulating Hormone; Hot Flashes; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Menopause; Menorrhagia; Odds Ratio | 2004 |
Intrauterine levonorgestrel delivered by a frameless system, combined with systemic estrogen: acceptability and endometrial safety after 3 years of use in peri- and postmenopausal women.
Topics: Administration, Cutaneous; Adult; Aged; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Menopause; Middle Aged; Patient Satisfaction; Prospective Studies; Treatment Outcome; Ultrasonography | 2005 |
L-norgestrel and progesterone have different influences on plasma lipoproteins.
Topics: Cholesterol; Contraceptives, Oral, Combined; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Middle Aged; Norgestrel; Phospholipids; Progesterone; Triglycerides | 1983 |
Endometrial suppression with a new 'frameless' levonorgestrel releasing intrauterine system in perimenopausal and postmenopausal women: a pilot study.
Topics: Adult; Drug Delivery Systems; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged; Pilot Projects; Progesterone Congeners; Ultrasonography | 2000 |
Efficacy of a new 7-day transdermal sequential estradiol/levonorgestrel patch in women.
Topics: Administration, Cutaneous; Adult; Aged; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Germany; Hot Flashes; Humans; Levonorgestrel; Menopause; Middle Aged; Treatment Outcome | 2002 |
Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women.
Topics: Bone Density; Calcaneus; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Forearm; Humans; Levonorgestrel; Longitudinal Studies; Lumbar Vertebrae; Menopause; Middle Aged | 1992 |
Short term effects of SHD 386L and levonorgestrel on bone and mineral metabolism in the postmenopause: a double-blind randomised placebo-controlled trial.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Creatinine; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyproline; Levonorgestrel; Luteinizing Hormone; Menopause; Middle Aged; Minerals; Osteocalcin; Osteoporosis, Postmenopausal; Time Factors | 1992 |
Intrauterine release of levonorgestrel--a new way of adding progestogen in hormone replacement therapy.
Topics: Biopsy; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged; Uterine Hemorrhage; Uterus | 1992 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
Topics: Administration, Oral; Biotransformation; Estradiol; Estrogens; Estrone; Female; Half-Life; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Random Allocation; Sex Hormone-Binding Globulin | 1990 |
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Random Allocation | 1989 |
Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Progesterone; Random Allocation | 1989 |
Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norgestrel; Triglycerides | 1987 |
Clinical experience with a low-dose combination of estradiol valerate and levonorgestrel. Double-blind comparative study between SH D 386 F and Cyclabil. Effects on symptoms, lipids and endometrial condition.
Topics: Adult; Cholesterol; Cholesterol, HDL; Climacteric; Clinical Trials as Topic; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Random Allocation; Triglycerides | 1986 |
36 other study(ies) available for levonorgestrel and Menopause
| Article | Year |
|---|---|
The Role of Progestogens in Menopausal Hormone Therapy.
Topics: Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menopause; Progesterone; Progestins | 2021 |
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition.
Topics: Adult; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged; Postmenopause | 2023 |
[How to diagnose menopause? Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].
Topics: Female; Humans; Intrauterine Devices; Levonorgestrel; Menopause; Middle Aged; Postmenopause; Retrospective Studies | 2021 |
Potential health benefits of continuous LNG-IUS combined with parenteral ERT for seamless menopausal transition and beyond--a commentary based on clinical experience.
Topics: Aged; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Humans; Infusions, Parenteral; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged; Patient Acceptance of Health Care; Retrospective Studies; Risk Assessment | 2013 |
Effectiveness, tolerability and acceptance of an oral estradiol/levonorgestrel formulation for the treatment of menopausal complaints: a non-interventional observational study over six cycles of 28 days.
Topics: Adult; Aged; Drug Combinations; Estradiol; Estrogens; Female; Germany; Hormone Replacement Therapy; Humans; Levonorgestrel; Menopause; Middle Aged; Patient Satisfaction; Progestins; Severity of Illness Index; Time Factors; Treatment Outcome | 2014 |
[Contraceptives in the perimenopause: Safe prevention and treatment of menopausal symptoms?].
Topics: Adult; Contraceptives, Oral, Hormonal; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged | 2010 |
Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device?
Topics: Adult; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menorrhagia; Middle Aged; Patient Satisfaction; Retrospective Studies | 2011 |
Comparing the effects of intrauterine progestin system and oral progestin on health-related quality of life and Kupperman index in hormone replacement therapy.
Topics: Administration, Oral; Aged; Estradiol; Estrogen Replacement Therapy; Female; Health Status; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Middle Aged; Progestins; Quality of Life | 2011 |
ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices.
Topics: Abortion, Induced; Abortion, Spontaneous; Actinomyces; Antibiotic Prophylaxis; Bone Density; Breast Feeding; Cervix Uteri; Contraceptive Agents, Female; Copper; Desogestrel; Device Removal; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menstrual Cycle; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Sexually Transmitted Diseases | 2011 |
Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Menopause; Middle Aged; Prognosis; Treatment Failure; Young Adult | 2012 |
Contraception for the older woman.
Topics: Age Factors; Behavior; Biology; Coitus; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Demography; Endocrine System; Family Planning Services; Fertility; Hormones; Injections; Intrauterine Devices; Levonorgestrel; Menopause; Patient Acceptance of Health Care; Physiology; Population; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Sexual Behavior; Smoking; Social Behavior; Sterilization, Reproductive | 1985 |
Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study.
Topics: Adult; Amenorrhea; Attitude; Coitus; Contraceptive Agents, Female; Dysmenorrhea; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menstruation; Middle Aged; Patient Satisfaction; Pregnancy | 2003 |
17Beta-estradiol/levonorgestrel transdermal system for the management of the symptomatic menopausal woman.
Topics: Contraceptive Agents, Female; Estradiol; Female; Humans; Levonorgestrel; Menopause | 2004 |
[Management of abnormal uterine bleeding].
Topics: Algorithms; Catheter Ablation; Contraceptive Agents, Female; Embolization, Therapeutic; Endometrium; Female; Humans; Levonorgestrel; Menopause; Uterine Hemorrhage | 2006 |
Menopausal symptoms.
Topics: Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menopause | 2007 |
High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol.
Topics: Administration, Cutaneous; Administration, Oral; Analysis of Variance; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Drug Administration Routes; Estradiol; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Inflammation; Intrauterine Devices, Medicated; Levonorgestrel; Lipids; Medroxyprogesterone Acetate; Menopause; Middle Aged; Risk Factors | 2007 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combined; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progesterone Congeners; Time Factors | 1983 |
Lipoprotein levels during hormone replacement therapy by vaginal ring pessaries.
Topics: Adult; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Middle Aged; Norgestrel; Pessaries | 1984 |
Reduction of plasma high-density lipoprotein cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment.
Topics: Cholesterol; Cholesterol, HDL; Female; Heparin; Humans; Levonorgestrel; Lipase; Lipoproteins, HDL; Liver; Menopause; Menstruation Disturbances; Middle Aged; Norgestrel; Stereoisomerism | 1981 |
The value of endometrial cell sampling in the management of post-menopausal women.
Topics: Cytodiagnosis; Dilatation and Curettage; Endometrial Hyperplasia; Endometrium; Estrogens; Female; Humans; Levonorgestrel; Menopause; Norgestrel; Polyps; Stereoisomerism; Uterine Neoplasms | 1981 |
Effects of oestradiol on sex hormone binding globulin.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Female; Humans; Levonorgestrel; Menopause; Menotropins; Menstruation; Norgestrel; Ovulation; Progesterone; Sex Hormone-Binding Globulin | 1982 |
Hormone replacement therapy and sexuality in women.
Topics: Adult; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hysterectomy; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Sexual Behavior | 1982 |
[Hormonal therapy in perimenopause].
Topics: Adult; Age Factors; Climacteric; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Menopause; Middle Aged; Postmenopause; Syndrome | 1995 |
The effect of a new sequential oestradiol valerate and levonorgestrel preparation on the bone mineral density of postmenopausal women.
Topics: Bone Density; Contraceptives, Oral, Combined; Estradiol; Estrogen Replacement Therapy; Female; Hip Joint; Humans; Levonorgestrel; Lumbar Vertebrae; Menopause; Middle Aged | 1993 |
Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.
Topics: Cerebrovascular Disorders; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Menopause; Middle Aged; Multivariate Analysis; Risk Factors; Sweden; Time Factors | 1993 |
Left ventricular diastolic function by Doppler echocardiography in relation to hormonal replacement therapy in healthy postmenopausal women.
Topics: Alcohol Drinking; Blood Flow Velocity; Body Mass Index; Diastole; Echocardiography, Doppler; Estradiol; Estrogen Replacement Therapy; Female; Heart Rate; Humans; Levonorgestrel; Medroxyprogesterone; Menopause; Middle Aged; Reference Values; Ventricular Function, Left | 1993 |
Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Topics: Administration, Oral; Atrophy; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Gels; Humans; Intrauterine Devices; Levonorgestrel; Menopause; Middle Aged; Prospective Studies; Time Factors | 1998 |
The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasonographically assessed atherosclerotic plaque quantity and severity in postmenopausal women.
Topics: Aged; Arteries; Arteriosclerosis; Autoantibodies; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipoproteins, LDL; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Progesterone Congeners; Reference Values; Severity of Illness Index; Time Factors; Ultrasonography | 2001 |
[Evaluation of selected X syndrome factors during hormonal replacement therapy].
Topics: Aged; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Levonorgestrel; Menopause; Metabolic Syndrome; Middle Aged; Time Factors; Triglycerides | 2001 |
Effects of treatment with oestradiol/levonorgestrel on bone, lipoproteins and hormone status in postmenopausal women.
Topics: Administration, Intravaginal; Bone and Bones; Bone Density; Bone Resorption; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipoproteins; Menopause; Norgestrel; Pessaries | 1989 |
Pharmacokinetics of progestational compounds.
Topics: Absorption; Aged; Blood Proteins; Drug Interactions; Female; Humans; Kinetics; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Norgestrel; Osmolar Concentration; Progestins | 1986 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Ovarian function during oestrogen-progestin replacement treatment in pre-menopausal women.
Topics: Adult; Estradiol; Estrogens, Conjugated (USP); Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Menopause; Menstrual Cycle; Middle Aged; Norgestrel; Ovary; Progesterone; Stereoisomerism; Ultrasonics | 1986 |
Endometrial effects of a continuous percutaneous oestrogen/low dose oral progestogen regimen for climacteric complaints.
Topics: Administration, Cutaneous; Administration, Oral; Cell Division; Climacteric; Drug Therapy, Combination; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menopause; Norgestrel | 1987 |
Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women.
Topics: Administration, Oral; Bone and Bones; Cross-Sectional Studies; Estradiol; Estrogens; Female; Humans; Hydroxyapatites; Injections, Subcutaneous; Levonorgestrel; Menopause; Middle Aged; Norgestrel; Osteoporosis; Testosterone | 1988 |
The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Estrone; Female; Humans; Levonorgestrel; Lipids; Menopause; Middle Aged; Norgestrel | 1985 |